Cholangiocarcinoma in an immunosuppressed kidney transplant patient. A case report and review of literature.
Immunosuppressed transplant recipients are susceptible to an increased incidence of certain malignancies. There is a significant relationship between tumour incidence and HLA-A and HLA-B mismatch. We present a patient who developed a cholangiocarcinoma ten years after a cadaveric donor renal transplant. Carcinoma of the main hepatic duct junction is a rare and difficult condition to treat. Surgical resection offers the best prolonged survival, but is rarely possible. Most of these patients will therefore require palliative biliary decompression.